$AMRX
Amneal Pharmaceuticals, Inc.

2021 Q2 Form 10-Q Financial Statement

#000172312821000032 Filed on August 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $535.1M $464.7M
YoY Change 15.15% 14.83%
Cost Of Revenue $322.6M $319.7M
YoY Change 0.91% 7.86%
Gross Profit $212.5M $144.2M
YoY Change 47.33% 37.04%
Gross Profit Margin 39.71% 31.04%
Selling, General & Admin $86.16M $80.94M
YoY Change 6.44% 20.31%
% of Gross Profit 40.54% 56.12%
Research & Development $52.86M $45.57M
YoY Change 16.0% -5.09%
% of Gross Profit 24.88% 31.6%
Depreciation & Amortization $56.54M $58.10M
YoY Change -2.69% 14.6%
% of Gross Profit 26.61% 40.28%
Operating Expenses $139.0M $126.5M
YoY Change 9.88% 9.73%
Operating Profit $67.12M $10.75M
YoY Change 524.3% -156.84%
Interest Expense -$34.08M -$36.67M
YoY Change -7.05% -16.44%
% of Operating Profit -50.78% -341.08%
Other Income/Expense, Net -$32.30M -$32.51M
YoY Change -0.66% -12.88%
Pretax Income $34.82M -$21.76M
YoY Change -260.05% -61.3%
Income Tax $2.600M $2.000M
% Of Pretax Income 7.47%
Net Earnings $29.99M -$24.16M
YoY Change -224.12% 42.97%
Net Earnings / Revenue 5.61% -5.2%
Basic Earnings Per Share $0.10 -$0.08
Diluted Earnings Per Share $0.10 -$0.08
COMMON SHARES
Basic Shares Outstanding 149.0M shares 147.4M shares
Diluted Shares Outstanding 152.0M shares 147.4M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $278.3M $266.1M
YoY Change 4.59% 384.7%
Cash & Equivalents $278.3M $266.1M
Short-Term Investments
Other Short-Term Assets $43.52M $50.00M
YoY Change -12.96% -36.87%
Inventory $523.4M $444.0M
Prepaid Expenses
Receivables $652.0M $582.7M
Other Receivables $43.88M $12.65M
Total Short-Term Assets $1.563B $1.481B
YoY Change 5.58% 24.88%
LONG-TERM ASSETS
Property, Plant & Equipment $468.4M $460.5M
YoY Change 1.71% -9.36%
Goodwill $549.1M $527.5M
YoY Change 4.1% 25.58%
Intangibles $1.293B $1.424B
YoY Change -9.17% -8.34%
Long-Term Investments
YoY Change
Other Assets $19.22M $28.73M
YoY Change -33.12% -54.73%
Total Long-Term Assets $2.460B $2.576B
YoY Change -4.52% -16.27%
TOTAL ASSETS
Total Short-Term Assets $1.563B $1.481B
Total Long-Term Assets $2.460B $2.576B
Total Assets $4.023B $4.057B
YoY Change -0.83% -4.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $596.2M $599.5M
YoY Change -0.55% 18.69%
Accrued Expenses $10.44M $16.30M
YoY Change -35.96% 4.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $30.46M $29.76M
YoY Change 2.37% 32.25%
Total Short-Term Liabilities $672.9M $655.0M
YoY Change 2.72% 19.93%
LONG-TERM LIABILITIES
Long-Term Debt $2.720B $2.765B
YoY Change -1.61% 5.53%
Other Long-Term Liabilities $63.26M $93.77M
YoY Change -32.54% 227.27%
Total Long-Term Liabilities $2.946B $3.018B
YoY Change -2.4% 1.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $672.9M $655.0M
Total Long-Term Liabilities $2.946B $3.018B
Total Liabilities $3.619B $3.673B
YoY Change -1.49% 4.57%
SHAREHOLDERS EQUITY
Retained Earnings -$265.6M -$274.8M
YoY Change -3.36% 240.34%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $346.1M $306.0M
YoY Change
Total Liabilities & Shareholders Equity $4.023B $4.057B
YoY Change -0.83% -4.82%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $29.99M -$24.16M
YoY Change -224.12% 42.97%
Depreciation, Depletion And Amortization $56.54M $58.10M
YoY Change -2.69% 14.6%
Cash From Operating Activities -$51.91M $179.3M
YoY Change -128.95% 749.76%
INVESTING ACTIVITIES
Capital Expenditures -$9.052M -$8.600M
YoY Change 5.26% -86.04%
Acquisitions
YoY Change
Other Investing Activities -$73.83M -$400.0K
YoY Change 18357.0% -101.04%
Cash From Investing Activities -$82.88M -$9.000M
YoY Change 820.89% -61.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -38.12M -310.1M
YoY Change -87.71% 3345.56%
NET CHANGE
Cash From Operating Activities -51.91M 179.3M
Cash From Investing Activities -82.88M -9.000M
Cash From Financing Activities -38.12M -310.1M
Net Change In Cash -172.9M -139.8M
YoY Change 23.68% 1148.21%
FREE CASH FLOW
Cash From Operating Activities -$51.91M $179.3M
Capital Expenditures -$9.052M -$8.600M
Free Cash Flow -$42.85M $187.9M
YoY Change -122.81% 127.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity File Number
EntityFileNumber
001-38485
dei Entity Central Index Key
EntityCentralIndexKey
0001723128
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
Amneal Pharmaceuticals, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
32-0546926
dei Entity Address Address Line1
EntityAddressAddressLine1
400 Crossing Boulevard,
dei Entity Address City Or Town
EntityAddressCityOrTown
Bridgewater
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08807
dei City Area Code
CityAreaCode
908
dei Local Phone Number
LocalPhoneNumber
947-3120
dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
AMRX
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
535075000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
464662000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1028180000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
963195000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
322577000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
319666000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
624120000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
633244000 USD
CY2021Q2 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
0 USD
CY2020Q2 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
759000 USD
amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
0 USD
amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
2215000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
212498000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
144237000 USD
us-gaap Gross Profit
GrossProfit
404060000 USD
us-gaap Gross Profit
GrossProfit
327736000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86157000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80944000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176883000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158920000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52864000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45572000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
710000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101046000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
81951000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
710000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
960000 USD
CY2021Q2 us-gaap Royalty Expense
RoyaltyExpense
1365000 USD
CY2020Q2 us-gaap Royalty Expense
RoyaltyExpense
3550000 USD
us-gaap Royalty Expense
RoyaltyExpense
4947000 USD
us-gaap Royalty Expense
RoyaltyExpense
4820000 USD
CY2021Q2 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
4283000 USD
CY2020Q2 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
1787000 USD
amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
7085000 USD
amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
4362000 USD
CY2021Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
CY2020Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1300000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5800000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
333000 USD
us-gaap Restructuring Charges
RestructuringCharges
363000 USD
us-gaap Restructuring Charges
RestructuringCharges
2381000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
67119000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
10751000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
113026000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
68542000 USD
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-34083000 USD
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-36669000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-67968000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-76568000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2244000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3466000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-156000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1715000 USD
CY2021Q2 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
CY2020Q2 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
123000 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
123000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4032000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
571000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4826000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1204000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32295000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32509000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-63298000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-76956000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
34824000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21758000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49728000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8414000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2648000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2186000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3007000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-105987000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
32176000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-23944000 USD
us-gaap Profit Loss
ProfitLoss
46721000 USD
us-gaap Profit Loss
ProfitLoss
97573000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17644000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11948000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
25483000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5498000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14532000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11996000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21238000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
103071000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148996000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147392000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148507000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147286000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151986000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147392000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151606000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148309000 shares
CY2021Q2 us-gaap Profit Loss
ProfitLoss
32176000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-23944000 USD
us-gaap Profit Loss
ProfitLoss
46721000 USD
us-gaap Profit Loss
ProfitLoss
97573000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17644000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11948000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
25483000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-5498000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14532000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11996000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21238000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
103071000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
182000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2967000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6184000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8102000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
704000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-9774000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
21476000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-72432000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
448000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-6471000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
7750000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-40927000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
438000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6270000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
7542000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-39607000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14970000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18266000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
28780000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
63464000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
278306000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
341378000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4847000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
5743000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
652015000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
638895000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
523385000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
490649000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
103798000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73467000 USD
CY2021Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1124000 USD
CY2020Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1407000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1563475000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1551539000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
468415000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
477754000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
549091000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
522814000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1293325000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1304626000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19216000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22344000 USD
CY2021Q2 us-gaap Assets
Assets
4023053000 USD
CY2020Q4 us-gaap Assets
Assets
4006033000 USD
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
596227000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
611867000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
30461000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
44228000 USD
CY2021Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
32930000 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
7561000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
672862000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
676902000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2720117000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2735264000 USD
CY2021Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
37224000 USD
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
36440000 USD
CY2021Q2 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
8714000 USD
CY2020Q4 us-gaap Due To Affiliate Noncurrent
DueToAffiliateNoncurrent
1584000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
63255000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
83365000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2945807000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2972395000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
14112000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
11804000 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
642657000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
628413000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-265583000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-286821000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-33979000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-41318000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
346107000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
303271000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
44165000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
41661000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390272000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
344932000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4023053000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4006033000 USD
us-gaap Profit Loss
ProfitLoss
46721000 USD
us-gaap Profit Loss
ProfitLoss
97573000 USD
amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
112037000 USD
amrx Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts
116155000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-124000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-1251000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4473000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4214000 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
123000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
710000 USD
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
3175000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12962000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
10202000 USD
us-gaap Inventory Write Down
InventoryWriteDown
25805000 USD
us-gaap Inventory Write Down
InventoryWriteDown
34708000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2764000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4156000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
13167000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-75769000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
54580000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
33182000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
110069000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
23988000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8772000 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-7383000 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-633000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21137000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15172000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3912000 USD
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-139000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
96195000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
228267000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19585000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15919000 USD
amrx Payments To Acquire Property Plant And Equipment Deposits
PaymentsToAcquirePropertyPlantAndEquipmentDeposits
1667000 USD
amrx Payments To Acquire Property Plant And Equipment Deposits
PaymentsToAcquirePropertyPlantAndEquipmentDeposits
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
500000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1050000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
73828000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
254000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95580000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-270969000 USD
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
0 USD
us-gaap Proceeds From Issuance Of Medium Term Notes
ProceedsFromIssuanceOfMediumTermNotes
180000000 USD
amrx Repayments Of Long Term Debt And Financing Lease Obligations
RepaymentsOfLongTermDebtAndFinancingLeaseObligations
33876000 USD
amrx Repayments Of Long Term Debt And Financing Lease Obligations
RepaymentsOfLongTermDebtAndFinancingLeaseObligations
17072000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4102000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
681000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
158000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2378000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
557000 USD
amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
27551000 USD
amrx Tax Distribution To Noncontrolling Interest Financing Activities
TaxDistributionToNoncontrollingInterestFinancingActivities
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1000000 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-64217000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
157897000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-366000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
255000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-63968000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
115450000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
347121000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152822000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283153000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268272000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
278306000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
266143000 USD
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
4847000 USD
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2129000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
283153000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
268272000 USD
us-gaap Interest Paid Net
InterestPaidNet
61441000 USD
us-gaap Interest Paid Net
InterestPaidNet
68433000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4610000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4518000 USD
amrx Tax Distribution To Non Controlling Interest
TaxDistributionToNonControllingInterest
0 USD
amrx Tax Distribution To Non Controlling Interest
TaxDistributionToNonControllingInterest
1573000 USD
amrx Noncash Or Part Noncash Acquisition Deferred Consideration For Acquisition Related Party
NoncashOrPartNoncashAcquisitionDeferredConsiderationForAcquisitionRelatedParty
30099000 USD
amrx Noncash Or Part Noncash Acquisition Deferred Consideration For Acquisition Related Party
NoncashOrPartNoncashAcquisitionDeferredConsiderationForAcquisitionRelatedParty
0 USD
amrx Noncash Or Part Noncash Acquisition Contingent Consideration For Acquisition Related Party
NoncashOrPartNoncashAcquisitionContingentConsiderationForAcquisitionRelatedParty
6100000 USD
amrx Noncash Or Part Noncash Acquisition Contingent Consideration For Acquisition Related Party
NoncashOrPartNoncashAcquisitionContingentConsiderationForAcquisitionRelatedParty
0 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
366708000 USD
CY2021Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
13079000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
29993000 USD
CY2021Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
2183000 USD
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
182000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7632000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000 USD
CY2021Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-308000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
704000 USD
CY2021Q2 amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
1150000 USD
CY2021Q2 amrx Noncontrolling Interest Decrease Redemptions Or Purchase Of Interests Decrease From Earnings Distributions
NoncontrollingInterestDecreaseRedemptionsOrPurchaseOfInterestsDecreaseFromEarningsDistributions
2000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390272000 USD
CY2021Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
14112000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
344932000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
11804000 USD
us-gaap Net Income Loss
NetIncomeLoss
42742000 USD
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
3979000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6184000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12962000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
681000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-2457000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
21476000 USD
amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
1671000 USD
amrx Noncontrolling Interest Decrease Redemptions Or Purchase Of Interests Decrease From Earnings Distributions
NoncontrollingInterestDecreaseRedemptionsOrPurchaseOfInterestsDecreaseFromEarningsDistributions
2000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390272000 USD
CY2021Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
14112000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
403458000 USD
CY2020Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
12563000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-24164000 USD
CY2020Q2 us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
220000 USD
CY2020Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2967000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5663000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
153000 USD
CY2020Q2 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-183000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-9774000 USD
CY2020Q2 amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
1170000 USD
CY2020Q2 amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
403000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
371016000 USD
CY2020Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
12380000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
346788000 USD
CY2019Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
0 USD
us-gaap Net Income Loss
NetIncomeLoss
96265000 USD
us-gaap Temporary Equity Net Income
TemporaryEquityNetIncome
1308000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-8102000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10202000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
158000 USD
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-693000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-72432000 USD
amrx Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders Tax Distribution
NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersTaxDistribution
1170000 USD
amrx Temporary Equity Tax Distribution
TemporaryEquityTaxDistribution
403000 USD
amrx Temporary Equity Redeemable Non Controlling Interests Issued For Acquisitions
TemporaryEquityRedeemableNonControllingInterestsIssuedForAcquisitions
11475000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
371016000 USD
CY2020Q2 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
12380000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, billbacks, valuation of intangible and other assets acquired in business combinations, allowances for accounts receivable, accrued liabilities, contingent consideration recognized in business combinations, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period balances related to (i) financing lease right-of-use assets of $10 million formerly included in other assets, (ii) current portion of financing lease liabilities of $2 million formerly included in accounts payable and accrued expenses, and (iii) long-term lease liabilities of $2 million formerly included in other long-term liabilities as of December 31, 2020 have been reclassified to their respective balance sheet captions to conform to the current period presentation in the consolidated balance sheets.</span></div>
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
10000000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2000000 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2000000 USD
CY2020Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
535075000 USD
CY2019Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
464755000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
1028372000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
994156000 USD
CY2020Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
34172000 USD
CY2019Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-26225000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
49199000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
85935000 USD
CY2020Q2 amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
15523000 USD
CY2019Q2 amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
-14104000 USD
amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
22475000 USD
amrx Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders
BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders
96390000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
535075000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
464662000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1028180000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
963195000 USD
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
14532000 USD
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11996000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
21238000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
103071000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148996000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147392000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
148507000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147286000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151986000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147392000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
151606000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
148309000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.70
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.69
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.076
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000000 USD
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.100
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.060
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-106000000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
12.597
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-110000000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
423000000 USD
CY2018Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
345000000 USD
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
-110000000 USD
CY2020Q3 amrx Income Taxes Receivable Net Operating Loss Cares Act Amount Refunded
IncomeTaxesReceivableNetOperatingLossCARESActAmountRefunded
106000000 USD
CY2020Q3 amrx Income Taxes Receivable Net Operating Loss Cares Act
IncomeTaxesReceivableNetOperatingLossCARESAct
110000000 USD
CY2020Q3 amrx Income Taxes Receivable Net Operating Loss Cares Act Interest
IncomeTaxesReceivableNetOperatingLossCARESActInterest
4000000 USD
CY2021Q1 amrx Income Taxes Receivable Net Operating Loss Cares Act Amount Refunded
IncomeTaxesReceivableNetOperatingLossCARESActAmountRefunded
2000000 USD
CY2018Q2 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2020Q4 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
206000000 USD
CY2021Q2 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
206000000 USD
CY2021Q2 amrx Percentage Of Tax Benefits Under Tax Receivable Agreement
PercentageOfTaxBenefitsUnderTaxReceivableAgreement
0.85
CY2020Q4 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
206000000 USD
CY2021Q2 amrx Liabilities Under Tax Receivable Agreement Noncurrent
LiabilitiesUnderTaxReceivableAgreementNoncurrent
206000000 USD
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1182837000 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1291785000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1546000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1396000 USD
CY2021Q2 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
506813000 USD
CY2020Q4 amrx Contract Charge Backs And Sales Volume Allowances Current
ContractChargeBacksAndSalesVolumeAllowancesCurrent
628804000 USD
CY2021Q2 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
22463000 USD
CY2020Q4 amrx Cash Discount Allowances Current
CashDiscountAllowancesCurrent
22690000 USD
CY2021Q2 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
530822000 USD
CY2020Q4 amrx Allowance For Accounts Receivable Current
AllowanceForAccountsReceivableCurrent
652890000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
652015000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
638895000 USD
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
216835000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
209180000 USD
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
46991000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40937000 USD
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
259559000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
240532000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
523385000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
490649000 USD
CY2021Q2 us-gaap Interest Rate Cash Flow Hedge Liability At Fair Value
InterestRateCashFlowHedgeLiabilityAtFairValue
32427000 USD
CY2021Q2 amrx Deferred Compensation Plan Liabilities Fair Value Disclosures
DeferredCompensationPlanLiabilitiesFairValueDisclosures
14848000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6100000 USD
CY2020Q4 us-gaap Interest Rate Cash Flow Hedge Liability At Fair Value
InterestRateCashFlowHedgeLiabilityAtFairValue
53903000 USD
CY2020Q4 amrx Deferred Compensation Plan Liabilities Fair Value Disclosures
DeferredCompensationPlanLiabilitiesFairValueDisclosures
14007000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6000000 USD
CY2021Q2 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-32000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
522814000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
419504000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
26530000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
103679000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-253000 USD
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-369000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
549091000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
522814000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1313345000 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
131000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
443005000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
870340000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1286896000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
361665000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
925231000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
422985000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
422985000 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
379395000 USD
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
379395000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1736330000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
443005000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1293325000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666291000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
361665000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1304626000 USD
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
74000000 USD
CY2021Q2 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
74000000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43520000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43976000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
85192000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
86552000 USD
CY2021Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
423000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
87054000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
162708000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
149824000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
139771000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
100382000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
56016000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
174585000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
870340000 USD
CY2021Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1000000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1000000 USD
CY2020Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
1000000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3000000 USD
CY2021Q2 us-gaap Loss Contingency Receivable
LossContingencyReceivable
33000000 USD
CY2020Q4 us-gaap Loss Contingency Receivable
LossContingencyReceivable
6000000 USD
CY2014Q4 amrx Number Of Sales Representatives
NumberOfSalesRepresentatives
1 representative
CY2021Q2 amrx Loss Contingency Pending Claims Including Third Parties Number
LossContingencyPendingClaimsIncludingThirdPartiesNumber
890 case
CY2021Q2 amrx Loss Contingency Number Of Cases
LossContingencyNumberOfCases
120 case
CY2021Q2 amrx Loss Contingency Number Of States With Cases
LossContingencyNumberOfStatesWithCases
11 state
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
amrx Number Of Product Families
NumberOfProductFamilies
250 product
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
535075000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
322577000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
212498000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
86157000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
52864000 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
710000 USD
CY2021Q2 us-gaap Royalty Expense
RoyaltyExpense
1365000 USD
CY2021Q2 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
4283000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
67119000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1028180000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
624120000 USD
us-gaap Gross Profit
GrossProfit
404060000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176883000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
101046000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
710000 USD
us-gaap Royalty Expense
RoyaltyExpense
4947000 USD
amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
7085000 USD
us-gaap Restructuring Charges
RestructuringCharges
363000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
113026000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
464662000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
319666000 USD
CY2020Q2 amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
759000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
144237000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80944000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45572000 USD
CY2020Q2 us-gaap Royalty Expense
RoyaltyExpense
3550000 USD
CY2020Q2 amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
1787000 USD
CY2020Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1300000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
333000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
10751000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
963195000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
633244000 USD
amrx Cost Of Goods And Services Sold Impairment Charges
CostOfGoodsAndServicesSoldImpairmentCharges
2215000 USD
us-gaap Gross Profit
GrossProfit
327736000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
158920000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
81951000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
960000 USD
us-gaap Royalty Expense
RoyaltyExpense
4820000 USD
amrx Business Combination Acquisition Related Costs Transaction Related And Integration Expense
BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense
4362000 USD
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5800000 USD
us-gaap Restructuring Charges
RestructuringCharges
2381000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
68542000 USD
CY2021Q2 amrx Business Combination Deferred Consideration Liability Fair Value Gross
BusinessCombinationDeferredConsiderationLiabilityFairValueGross
30000000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
6000000 USD
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
17000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
26000000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1000000 USD
amrx Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1200000 USD
CY2021Q2 amrx Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1700000 USD
amrx Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
400000 USD
CY2020Q2 amrx Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders
RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
400000 USD
CY2020 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-41203000 USD
CY2020 amrx Changes In Reallocation Of Ownership Interests
ChangesInReallocationOfOwnershipInterests
-47000 USD
us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
7542000 USD
amrx Changes In Reallocation Of Ownership Interests
ChangesInReallocationOfOwnershipInterests
-203000 USD
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1303000 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1696000 USD
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
7102000 USD
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
6916000 USD
CY2021Q2 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
1189000 USD
CY2020Q4 amrx Prepaid Regulatory Fees Current
PrepaidRegulatoryFeesCurrent
3565000 USD
CY2021Q2 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
11169000 USD
CY2020Q4 amrx Income And Other Taxes Receivable
IncomeAndOtherTaxesReceivable
11882000 USD
CY2021Q2 us-gaap Prepaid Taxes
PrepaidTaxes
5378000 USD
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
5542000 USD
CY2021Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
43875000 USD
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
17117000 USD
CY2021Q2 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
10083000 USD
CY2020Q4 amrx Chargebacks Receivable Current
ChargebacksReceivableCurrent
4913000 USD
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
23699000 USD
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
21836000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
103798000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73467000 USD
CY2021Q2 us-gaap Loss Contingency Receivable
LossContingencyReceivable
33000000 USD
CY2020Q4 us-gaap Loss Contingency Receivable
LossContingencyReceivable
6000000 USD

Files In Submission

Name View Source Status
0001723128-21-000032-index-headers.html Edgar Link pending
0001723128-21-000032-index.html Edgar Link pending
0001723128-21-000032.txt Edgar Link pending
0001723128-21-000032-xbrl.zip Edgar Link pending
amrx-20210630.htm Edgar Link pending
amrx-20210630.xsd Edgar Link pending
amrx-2021063010xqexx101.htm Edgar Link pending
amrx-2021063010xqexx311.htm Edgar Link pending
amrx-2021063010xqexx312.htm Edgar Link pending
amrx-2021063010xqexx313.htm Edgar Link pending
amrx-2021063010xqexx321.htm Edgar Link pending
amrx-2021063010xqexx322.htm Edgar Link pending
amrx-2021063010xqexx323.htm Edgar Link pending
amrx-20210630_cal.xml Edgar Link unprocessable
amrx-20210630_def.xml Edgar Link unprocessable
amrx-20210630_htm.xml Edgar Link completed
amrx-20210630_lab.xml Edgar Link unprocessable
amrx-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending